ROR1 and neoplasm: This lncRNA participates in the regulation of gene transcription in combination with the polycomb inhibitory complex 2, which was first reported in 2017, and may be a neoplasm biomarker for patients with mantle cell lymphoma [7].The lncRNA ROR1-AS1 has the ability to regulate certain tumors as one of the particular sections of ROR1, which could modulate some human diseases and biological behaviors.